Hmdb loader
Survey
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 10:06:37 UTC
Update Date2021-09-26 23:04:43 UTC
HMDB IDHMDB0252256
Secondary Accession NumbersNone
Metabolite Identification
Common NameFilgotinib
DescriptionFilgotinib belongs to the class of organic compounds known as phenylpyridines. These are polycyclic aromatic compounds containing a benzene ring linked to a pyridine ring through a CC or CN bond. Based on a literature review a significant number of articles have been published on Filgotinib. This compound has been identified in human blood as reported by (PMID: 31557052 ). Filgotinib is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Filgotinib is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
SynonymsNot Available
Chemical FormulaC21H23N5O3S
Average Molecular Weight425.51
Monoisotopic Molecular Weight425.152160795
IUPAC NameN-(5-{4-[(1,1-dioxo-1lambda6-thiomorpholin-4-yl)methyl]phenyl}-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide
Traditional NameN-(5-{4-[(1,1-dioxo-1lambda6-thiomorpholin-4-yl)methyl]phenyl}-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide
CAS Registry NumberNot Available
SMILES
O=C(NC1=NN2C(C=CC=C2C2=CC=C(CN3CCS(=O)(=O)CC3)C=C2)=N1)C1CC1
InChI Identifier
InChI=1S/C21H23N5O3S/c27-20(17-8-9-17)23-21-22-19-3-1-2-18(26(19)24-21)16-6-4-15(5-7-16)14-25-10-12-30(28,29)13-11-25/h1-7,17H,8-14H2,(H,23,24,27)
InChI KeyRIJLVEAXPNLDTC-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as phenylpyridines. These are polycyclic aromatic compounds containing a benzene ring linked to a pyridine ring through a CC or CN bond.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassPyridines and derivatives
Sub ClassPhenylpyridines
Direct ParentPhenylpyridines
Alternative Parents
Substituents
  • 2-phenylpyridine
  • Triazolopyridine
  • Benzylamine
  • Phenylmethylamine
  • N-arylamide
  • Aralkylamine
  • Monocyclic benzene moiety
  • Cyclopropanecarboxylic acid or derivatives
  • 1,4-thiazinane
  • Benzenoid
  • Azole
  • Heteroaromatic compound
  • Sulfone
  • 1,2,4-triazole
  • Secondary carboxylic acid amide
  • Amino acid or derivatives
  • Carboxamide group
  • Tertiary amine
  • Tertiary aliphatic amine
  • Carboxylic acid derivative
  • Azacycle
  • Hydrocarbon derivative
  • Organooxygen compound
  • Organonitrogen compound
  • Organic oxide
  • Carbonyl group
  • Organic oxygen compound
  • Organic nitrogen compound
  • Amine
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP1.99ALOGPS
logP2.03ChemAxon
logS-3.4ALOGPS
pKa (Strongest Acidic)11.71ChemAxon
pKa (Strongest Basic)3.32ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count6ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area96.67 ŲChemAxon
Rotatable Bond Count5ChemAxon
Refractivity126.12 m³·mol⁻¹ChemAxon
Polarizability45.12 ųChemAxon
Number of Rings5ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+196.66230932474
DeepCCS[M-H]-194.30430932474
DeepCCS[M-2H]-227.96130932474
DeepCCS[M+Na]+203.06830932474
AllCCS[M+H]+200.732859911
AllCCS[M+H-H2O]+198.332859911
AllCCS[M+NH4]+202.932859911
AllCCS[M+Na]+203.532859911
AllCCS[M-H]-197.232859911
AllCCS[M+Na-2H]-197.432859911
AllCCS[M+HCOO]-197.932859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
FilgotinibO=C(NC1=NN2C(C=CC=C2C2=CC=C(CN3CCS(=O)(=O)CC3)C=C2)=N1)C1CC14749.5Standard polar33892256
FilgotinibO=C(NC1=NN2C(C=CC=C2C2=CC=C(CN3CCS(=O)(=O)CC3)C=C2)=N1)C1CC14158.5Standard non polar33892256
FilgotinibO=C(NC1=NN2C(C=CC=C2C2=CC=C(CN3CCS(=O)(=O)CC3)C=C2)=N1)C1CC14483.3Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Filgotinib,1TMS,isomer #1C[Si](C)(C)N(C(=O)C1CC1)C1=NN2C(C3=CC=C(CN4CCS(=O)(=O)CC4)C=C3)=CC=CC2=N14004.5Semi standard non polar33892256
Filgotinib,1TMS,isomer #1C[Si](C)(C)N(C(=O)C1CC1)C1=NN2C(C3=CC=C(CN4CCS(=O)(=O)CC4)C=C3)=CC=CC2=N13849.7Standard non polar33892256
Filgotinib,1TMS,isomer #1C[Si](C)(C)N(C(=O)C1CC1)C1=NN2C(C3=CC=C(CN4CCS(=O)(=O)CC4)C=C3)=CC=CC2=N15902.1Standard polar33892256
Filgotinib,1TBDMS,isomer #1CC(C)(C)[Si](C)(C)N(C(=O)C1CC1)C1=NN2C(C3=CC=C(CN4CCS(=O)(=O)CC4)C=C3)=CC=CC2=N14221.7Semi standard non polar33892256
Filgotinib,1TBDMS,isomer #1CC(C)(C)[Si](C)(C)N(C(=O)C1CC1)C1=NN2C(C3=CC=C(CN4CCS(=O)(=O)CC4)C=C3)=CC=CC2=N14108.8Standard non polar33892256
Filgotinib,1TBDMS,isomer #1CC(C)(C)[Si](C)(C)N(C(=O)C1CC1)C1=NN2C(C3=CC=C(CN4CCS(=O)(=O)CC4)C=C3)=CC=CC2=N15814.2Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Filgotinib GC-MS (Non-derivatized) - 70eV, Positivesplash10-017l-3109000000-a12fd491f465b1bde5322021-09-24Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Filgotinib GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Filgotinib 10V, Positive-QTOFsplash10-004i-0030900000-2f1a4b3891c32430c6772021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Filgotinib 20V, Positive-QTOFsplash10-004i-0033900000-18f8a53b251a61fe77372021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Filgotinib 40V, Positive-QTOFsplash10-0udl-0291000000-6457cb04c93f15f5f6bf2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Filgotinib 10V, Negative-QTOFsplash10-00di-0000900000-b7b7e3e09c73e5f9511a2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Filgotinib 20V, Negative-QTOFsplash10-00dl-1109500000-ed3dba352de355ebaf262021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Filgotinib 40V, Negative-QTOFsplash10-01ox-9155000000-59b830b63e208489a4302021-10-12Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID28189566
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkFilgotinib
METLIN IDNot Available
PubChem Compound49831257
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]